Validation of the European Society of Urogenital Radiology Scoring System for Prostate Cancer Diagnosis on Multiparametric Magnetic Resonance Imaging in a Cohort of Repeat Biopsy Patients

Hoeks, 2011, Prostate cancer: multiparametric MR imaging for detection, localization, and staging, Radiology, 261, 46, 10.1148/radiol.11091822

Portalez, 2010, Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies, Eur Radiol, 20, 2781, 10.1007/s00330-010-1868-6

Heidenreich, 2011, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease, Eur Urol, 59, 61, 10.1016/j.eururo.2010.10.039

Heijmink, 2011, State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer, Acta Oncol, 50, 25, 10.3109/0284186X.2010.578369

Giannarini, 2012, Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature, Eur Urol, 61, 326, 10.1016/j.eururo.2011.09.019

Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009

Kirkham, 2006, How good is MRI at detecting and characterising cancer within the prostate?, Eur Urol, 50, 1163, 10.1016/j.eururo.2006.06.025

Weinreb, 2009, Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy—results of ACRIN prospective multi-institutional clinicopathologic study, Radiology, 251, 122, 10.1148/radiol.2511080409

Villers, 2009, Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance, Curr Opin Urol, 19, 274, 10.1097/MOU.0b013e328329a2ed

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

Molleran, 2010, The BI-RADS breast magnetic resonance imaging lexicon, Magn Reson Imaging Clin N Am, 18, 171, 10.1016/j.mric.2010.02.001

Baumann, 2012, Prostate biopsy tracking with deformation estimation, Med Image Analysis, 16, 562, 10.1016/j.media.2011.01.008

Cornud, 2012, Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria?, Eur J Radiol, 81, e591, 10.1016/j.ejrad.2011.06.056

Ukimura, 2012, 3-dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion, J Urol, 187, 1080, 10.1016/j.juro.2011.10.124

Likert, 1932, A technique for the measurement of attitudes, Arch Psychol, 140, 1

Harnden, 2008, The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression?. a systematic review and meta-analysis, Cancer, 112, 971, 10.1002/cncr.23277

Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281, 10.1016/j.juro.2011.05.078

Agrawal, 2009, Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon, Cancer, 115, 1363, 10.1002/cncr.24156

Rouse, 2011, Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study, Urol Int, 87, 49, 10.1159/000325880

Haffner, 2011, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, BJU Int, 108, E171, 10.1111/j.1464-410X.2011.10112.x

Sclaverano, 2009, BiopSym: a simulator for enhanced learning of ultrasound-guided prostate biopsy, Stud Health Technol Inform, 142, 301

Lawrentschuk, 2009, Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy, J Urol, 182, 2659, 10.1016/j.juro.2009.08.036

Levine, 1998, Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer, J Urol, 159, 471, 10.1016/S0022-5347(01)63951-X

Djavan, 2001, Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study, J Urol, 166, 856, 10.1016/S0022-5347(05)65851-X

Washington, 2012, Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer, BJU Int, 110, 50, 10.1111/j.1464-410X.2011.10704.x

Sinnott, 2012, Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy, Prostate, 72, 1179, 10.1002/pros.22467

Lattouf, 2002, Gleason score on biopsy: is it reliable for predicting the final grade on pathology?, BJU Int, 90, 694, 10.1046/j.1464-410X.2002.02990.x

De Laet, 2009, Predicting tumour location in radical prostatectomy specimens: same-patient comparisons of 21-sample versus sextant biopsy, BJU Int, 104, 616, 10.1111/j.1464-410X.2009.08468.x

McGill, 2011, Precision grid and hand motion for accurate needle insertion in brachytherapy, Med Phys, 38, 4749, 10.1118/1.3611040

Hadaschik, 2011, A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion, J Urol, 186, 2214, 10.1016/j.juro.2011.07.102

Turkbey, 2011, Documenting the location of prostate biopsies with image fusion, BJU Int, 107, 53, 10.1111/j.1464-410X.2010.09483.x

Natarajan, 2011, Clinical application of a 3D ultrasound-guided prostate biopsy system, Urol Oncol, 29, 334, 10.1016/j.urolonc.2011.02.014

Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520, 10.1016/j.juro.2009.10.022